Introduction
============

Obesity is a determinant factor in the development of hypertension, diabetes, dyslipidemia, and cardiovascular damage.[@b1-cia-8-1579]--[@b4-cia-8-1579] Central arterial stiffness, an effective reflection of arterial structure, is assessed by carotid-femoral pulse wave velocity (cfPWV), and central hemodynamics is evaluated by central pulse pressure (cPP), a non-invasive representation of arterial function; both are important predictors of cardiovascular morbidity and mortality.[@b5-cia-8-1579]--[@b7-cia-8-1579] Several studies have analyzed the relationship between obesity and central arterial stiffness and hemodynamics.[@b8-cia-8-1579]--[@b11-cia-8-1579] For example, similar relationship between aortic stiffness and body weight have been documented in both the Cardiovascular Health Study and the Health ABC study.[@b12-cia-8-1579],[@b13-cia-8-1579] But, limited studies have specially compared overall and abdominal obesity in relation to central arterial stiffness and hemodynamics. A Spanish study of 305 subjects, by Recio-Rodriguez et al, has shown that waist circumference (WC) correlates better than body mass index (BMI) with arterial stiffness, measured by pulse wave velocity (PWV).[@b14-cia-8-1579] To our knowledge, few large sample studies have elucidated whether such relationship differs in community-dwelling adults, especially in the People's Republic of China; a large sample investigation directed at Chinese community-dwelling adults is imperative. Thus, the main objective of this study was to compare possible relationship of an overall obesity indicator (BMI), and an abdominal obesity index (WC), with parameters that measure central arterial stiffness (PWV) and hemodynamics (cPP), independent of age, sex, blood pressure, glucose, and lipids, in Chinese community-dwelling adults.

Subjects and methods
====================

Study population
----------------

This is an analysis of baseline data from a large health checkup program of community-dwelling residents in Beijing, People's Republic of China. A stratified cluster sampling design was used in this survey. In the first stage of sampling, three districts (Fengtai, Shijingshan, and Daxing) were selected from 18 districts in Beijing. In the second stage of sampling, four communities were selected from these districts. In the third stage of sampling, individual participants were selected from these communities. The inclusion period started in May 2007 and ended in July 2009. A total of 2,624 subjects were included in the analysis. Each subject was a permanent resident of Han origin, more than 18 years old.

Anthropometric measurements
---------------------------

All anthropometrics and blood pressure were measured by physicians in the Chinese People's Liberation Army General Hospital, who had been well trained by the research team. Weight was measured on a digital scale while subjects wore light clothing with no shoes. Height was determined using a wall-mounted measuring tape, subjects standing with no shoes. BMI was calculated as weight (kg) divided by height squared (m^2^). WC was measured in standing subjects using a flexible tape, midway between the lowest rib and the iliac crest. Overall obesity was defined as BMI greater than or equal to 28 kg/m^2^. Abdominal obesity was considered as WC greater than or equal to 85 cm, in males, and WC greater than or equal to 80 cm, in females, according to the 2006 Guidelines on Preservation and Control Overweight and Obesity in Chinese Adults classification.[@b15-cia-8-1579]

Peripheral artery blood pressure measurement
--------------------------------------------

Peripheral blood pressure was measured with a standard mercury sphygmomanometer, using the first and fifth Korotkoff sounds as the systolic and diastolic blood pressure, while the subjects were in a sedentary position, having rested for at least 5 minutes. The appropriate size cuff was determined based on arm circumference. Peripheral pulse pressure (pPP) is the difference between systolic and diastolic blood pressures.

Arterial stiffness and central hemodynamics analyses
----------------------------------------------------

Arterial stiffness was assessed by automated measurement of carotid-femoral pulse wave velocity (cfPWV) using a Complior Colson device (Créatech, Besançon, France), in the morning, in a quiet environment, at stable temperature. The technical characteristics of this device have been described previously.[@b16-cia-8-1579] Participants were studied in the supine position, after resting for at least 5 minutes. PWV along the artery was measured using two strain gauge transducers (TY-306 pressure-sensitive transducer, Fukuda Denshi Co, Tokyo, Japan), fixed transcutaneously over the course of the arteries, separated by a known distance; the right-side carotid, femoral, and radial arteries were used. After waveforms of sufficient quality were recorded, the digitization process was initiated by the operator, and automatic calculation of the time delay between two upstrokes was begun. Measurements were repeated over ten cardiac cycles, and the mean value was used in the final analysis. PWV was calculated from the measurement of the pulse transit time and distance traveled by the pulse between the two recording sites (measured on the surface of the body, in meters), according to the following formula: PWV (m/s) =distance (m)/transit time (s). The right radial artery pressure wave waveform was recorded using an instrument designed for such measurements (SphygmoCor, AtCor Medical Pty, West Ryde, NSW, Australia). The radial artery was gently compressed with the tip of a tonometer at the site of maximal pulsation. The tonometer contains a micromanometer, which provides a very accurate recording of the pressure within the artery. The system software was used to calculate the average radial artery waveform; the corresponding central artery pressure waveform and cPP were generated using a transfer function of the instrument.

Laboratory analyses
-------------------

Blood samples were collected between 8 am and 10 am, after subjects had fasted for at least 12 hours. Blood samples were stored at 4°C, and delivered to the central laboratory in the Department of Biochemistry, Chinese People's Liberation Army General Hospital on the same day. Serum fasting blood glucose (FBG), high density lipoprotein cholesterol (HDL-C), and low density lipoprotein cholesterol (LDL-C) levels were determined using enzymatic assays (Roche, Basel, Switzerland), on a fully automatic biochemical autoanalyzer (Cobas® 6000, Roche). The technicians who performed the different tests were blinded to the clinical data of the subjects.

Statistical analyses
--------------------

Categorical variables were expressed as numbers and percentages. Continuous variables were described using means with standard deviations, for data with normal distribution, and medians with interquartile ranges, for non-normally distributed data. The participants were stratified by the presence (or not) of overall and abdominal obesity. Simple comparison was made between groups using the Student's *t*-test for continuous variables (normal distribution), the Mann--Whitney *U* test for continuous variables (non-normal distribution), and the *χ*^2^ test for categorical variables. Logistic regression analysis was used to compare variables between groups after adjustment for age and sex. We logarithmically transformed cfPWV and cPP to meet the multinormality assumption, then performed multiple linear regression analysis, using cfPWV and cPP, as dependent variables, and BMI and WC, as independent variables, following two models. In the first model, age and sex were included as adjustment variables; and in the second model, age, sex, pPP, FBG, HDL-C, and LDL-C were included. All analyses were conducted using SPSS version 17 statistical software (IBM Corp, Armonk, NY, USA). A *P*-value \<0.05 was considered statistically significant.

Results
=======

The median age of all participants was 54 years, with an age range of 18--96 years; 51.8% were male. Median values of BMI and WC were 25.1 kg/m^2^ and 86 cm; 19.3% were overall obese and 63.1% were abdominally obese. Median values of cfPWV and cPP were 10.2 m/s and 37 mmHg, respectively. [Table 1](#t1-cia-8-1579){ref-type="table"} shows the demographic and clinical characteristics of all individuals, grouped by the presence (or not) of overall and abdominal obesity. Compared with non-obese individuals, both overall and abdominally obese individuals were older, with significantly higher cfPWV, cPP, pPP, FBG, and LDL-C levels, and lower HDL-C level (*P*\<0.001, for all). The percentages of males were similar between overall obese and non-obese groups, and between abdominally obese and non-obese groups (*P*\>0.05, for all). Compared with non-obese individuals, abdominally obese individuals had significantly higher BMI, and overall obese individuals had significantly higher WC (*P*\<0.001, for both). Compared with non-obese individuals, both overall obese and abdominally obese individuals had independently higher pPP, FBG, and LDL-C levels, and lower HDL-C level (*P*\<0.05, for all), after adjusting for age and sex. More importantly, compared with non-obese individuals, overall obese individuals had independently higher cPP (*P*\<0.05), but not cfPWV (*P*\>0.05), after adjusting for age and sex, while abdominally obese individuals had independently higher cfPWV (*P*\<0.05), but not cPP (*P*\>0.05).

In multivariate association analysis ([Table 2](#t2-cia-8-1579){ref-type="table"}), in the first and second models, WC (*P*\<0.05, for both), rather than BMI (*P*\>0.05, for both) was independently associated with cfPWV. Although both BMI and WC were both independently associated with cPP in the first model (*P*\<0.001, for both), only BMI (*P*\<0.001), and not WC (*P*\>0.05), was independently associated with cPP in the second model. In addition, age, sex, pPP, FBG, and HDL-C levels (*P*\<0.05, for all), but not LDL-C level (*P*\>0.05), were independently associated with cfPWV. Meanwhile, age, sex, pPP (*P*\<0.001, for all), but not FBG, HDL-C, and LDL-C levels (*P*\>0.05, for all), had independent association with cPP.

Discussion
==========

In Chinese community-dwelling adults, the current study demonstrated that WC, rather than BMI, was correlated with central arterial stiffness, as assessed by cfPWV, independent of age, sex, blood pressure, glucose, and lipids, while BMI, rather than WC, was independently associated with central hemodynamics, as measured by cPP. Moreover, age, sex, and blood pressure were independently associated with central arterial stiffness and hemodynamics, but blood glucose and lipids were independently associated with central arterial stiffness, rather than central hemodynamics.

Elevated central arterial stiffness and abnormal central hemodynamics reflect impairment of arterial structure and function and increased risk of cardiovascular disease, which leads to elevated mortality;[@b5-cia-8-1579],[@b6-cia-8-1579] hence, the measurements of central arterial stiffness and hemodynamics is beneficial to identify the cardiovascular damage. Although other methods exist to estimate central arterial stiffness and hemodynamics, PWV is widely used as the classical marker of central arterial stiffness, while cPP is well regarded as a non-invasive indicator of central hemodynamics.[@b7-cia-8-1579]

It is well known that metabolic disorders, including adiposity, can have an adverse influence on arterial structure and function. A line of studies has researched the relationship between obesity and central arterial stiffness and hemodynamics.[@b8-cia-8-1579]--[@b11-cia-8-1579] For example, similar relationship between aortic stiffness and body weight has been documented in both the Cardiovascular Health Study and Health ABC study.[@b12-cia-8-1579],[@b13-cia-8-1579] However, limited studies have been dedicated to comparing overall and abdominal obesity in relation to central arterial stiffness and hemodynamics. A study of 305 Spanish subjects, by Recio-Rodriguez et al, reminded us that WC correlated better than BMI with arterial stiffness, as measured by PWV.[@b14-cia-8-1579] The study had a small sample size, and was directed mainly toward hypertensive and diabetic subjects. Scarce large sample studies have elucidated whether the relationship might differ in Chinese community-dwelling adults. Previous studies have demonstrated that many Asians have different features of body shape, and those with lower BMI levels have higher amounts of body fat.[@b17-cia-8-1579] But studies analyzing the relationship of obesity with central arterial stiffness and hemodynamics have been based on data from United States or European countries, with little data available on populations in the People's Republic of China. Thus, there is a need for a large sample investigation in Chinese community-dwelling adults paying close attention to the comparison of overall and abdominal obesity in relation to central arterial stiffness and hemodynamics. The current study demonstrated that the measure of abdominal obesity (WC) rather than the overall obesity indicator (BMI) was associated with arterial stiffness, as evaluated by cfPWV, independent of age, sex, blood pressure, glucose, and lip-ids, while the overall obesity indicator (BMI), but not the abdominal obesity indicator (WC), was independently correlated with central hemodynamics, as evaluated by cPP.

There are a number of reasons why abdominal obesity might be more relevant to central arterial stiffening, as compared to overall obesity. First, insulin resistance has been shown to accompany abdominal obesity.[@b18-cia-8-1579],[@b19-cia-8-1579] Insulin resistance likely has vascular effects through associated hyperinsulinemia and increased glycemia. The effects of hyperinsulinemia on the vascular system might include promotion of sodium reabsorption,[@b20-cia-8-1579] stimulation of the sympathetic nervous system,[@b21-cia-8-1579] and promotion of vascular smooth muscle cell growth,[@b22-cia-8-1579] all of which might contribute to increased central arterial stiffness. The second mechanism by which abdominal obesity might contribute to central arterial stiffening is through inflammation, which has been shown to be related to abdominal obesity.[@b23-cia-8-1579] The presence of higher levels of circulating immune system cells possibly promotes their movement into the artery wall, leading to wall stiffening. Furthermore, sufficient attention must be paid to the shared genetic and epigenetic relationship between different types of obesity and central arterial stiffness and hemodynamics. The reason why overall obesity has a more significant relationship with central hemodynamics than abdominal obesity is not clear. Further experimental and clinical studies are needed.

Some limitations of the current study must be considered. First, due to its cross-sectional design, the study was inherently limited in its ability to determine causal relationship between different obesity indicators and central arterial stiffness and hemodynamics; further prospective, population-based studies are needed to investigate causal mechanisms. Second, since some of the study population might take different types of drugs, the current study failed to observe possible effects of drugs on central arterial stiffness and hemodynamics.

Based on the results obtained in our study, it can be concluded that in Chinese community-dwelling adults, the measure of abdominal obesity (WC), but not the overall obesity indicator (BMI), was related to central arterial stiffness, as represented by cfPWV, independent of age, sex, blood pressure, glucose, and lipids, while the overall obesity indicator (BMI), but not the abdominal obesity indicator (WC), was independently correlated with central hemodynamics, as measured by cPP. Furthermore, age, sex, and blood pressure were independently associated with central arterial stiffness and hemodynamics; and blood glucose and lipids were independently associated with central arterial stiffness, but not central hemodynamics.
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###### 

Demographic and clinical characteristics of all adults, by presence of overall and abdominal obesity

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristics                                            Overall non-obesity\   Overall obesity\       *P*-value[a](#tfn1-cia-8-1579){ref-type="table-fn"}   *P*-value[b](#tfn2-cia-8-1579){ref-type="table-fn"}   Abdominal non-obesity\   Abdominal obesity\     *P*-value[a](#tfn1-cia-8-1579){ref-type="table-fn"}   *P*-value[b](#tfn2-cia-8-1579){ref-type="table-fn"}
                                                             (n=2,117)              (n=507)                                                                                                                            (n=969)                  (n=1,655)                                                                    
  ---------------------------------------------------------- ---------------------- ---------------------- ----------------------------------------------------- ----------------------------------------------------- ------------------------ ---------------------- ----------------------------------------------------- -----------------------------------------------------
  Age (years)[c](#tfn3-cia-8-1579){ref-type="table-fn"}      53 (38--66)            56 (47--67)            \<0.001                                                                                                     46 (33--60)              58 (46--68)            \<0.001                                               

  Males (%)                                                  1,113 (52.6)           245 (48.3)             0.085                                                                                                       488 (50.4)               870 (52.6)             0.275                                                 

  BMI (kg/m^2^)[c](#tfn3-cia-8-1579){ref-type="table-fn"}    24.34 (22.38--25.95)   29.69 (28.67--31.26)   \<0.001                                                                                                     22.58 (20.83--24.15)     26.57 (24.97--28.41)   \<0.001                                               \<0.001

  WC (cm)[c](#tfn3-cia-8-1579){ref-type="table-fn"}          83 (77--89)            96 (91--101)           \<0.001                                               \<0.001                                               76 (71--79)              90 (86--95)            \<0.001                                               

  pPP (mmHg)[c](#tfn3-cia-8-1579){ref-type="table-fn"}       47 (40--58)            50 (42--62)            \<0.001                                               \<0.001                                               45 (38--54)              50 (40--60)            \<0.001                                               0.004

  FBG (mmol/L)[c](#tfn3-cia-8-1579){ref-type="table-fn"}     4.91 (4.54--5.35)      5.09 (4.64--5.70)      \<0.001                                               0.016                                                 4.81 (4.49--5.16)        5.03 (4.63--5.60)      \<0.001                                               \<0.001

  HDL-C (mmol/L)[c](#tfn3-cia-8-1579){ref-type="table-fn"}   1.38 (1.17--1.64)      1.22 (1.05--1.41)      \<0.001                                               \<0.001                                               1.52 (1.29--1.79)        1.26 (1.08--1.47)      \<0.001                                               \<0.001

  LDL-C (mmol/L)[c](#tfn3-cia-8-1579){ref-type="table-fn"}   2.70 (2.23--3.21)      2.95 (2.42--3.34)      \<0.001                                               \<0.001                                               2.50 (2.03--3.02)        2.89 (2.40--3.34)      \<0.001                                               \<0.001

  cfPWV (m/s)[c](#tfn3-cia-8-1579){ref-type="table-fn"}      10.1 (8.8--12.0)       10.5 (9.4--12.1)       \<0.001                                               0.518                                                 9.5 (8.4--11.0)          10.6 (9.2--12.5)       \<0.001                                               0.008

  cPP (mmHg)[c](#tfn3-cia-8-1579){ref-type="table-fn"}       37 (30--47)            40 (33--51)            \<0.001                                               \<0.001                                               35 (29--42)              39 (33--50)            \<0.001                                               0.193
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

*P*-value not adjusted

*P*-value adjusted for age and sex

median (interquartile range).

**Abbreviations:** BMI, body mass index; WC, waist circumference; pPP, peripheral pulse pressure; FBG, fasting blood glucose; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; cfPWV, carotid-femoral pulse wave velocity; cPP, central pulse pressure.

###### 

Multivariate association of pulse wave velocity and central pulse pressure with anthropometric measurements

  Characteristics                                          cfPWV    cPP                                  
  -------------------------------------------------------- -------- -------- --------- -------- -------- ---------
  **BMI (kg/m^2^)**                                                                                      
  First model[a](#tfn5-cia-8-1579){ref-type="table-fn"}                                                  
   BMI (kg/m^2^)                                           0.021    1.304    0.192     0.108    6.794    \<0.001
   Age (years)                                             0.588    35.361   \<0.001   0.564    34.571   \<0.001
   Females/males                                           −0.123   −7.441   \<0.001   0.031    1.924    0.054
  Second model[b](#tfn6-cia-8-1579){ref-type="table-fn"}                                                 
   BMI (kg/m^2^)                                           −0.020   −1.203   0.229     0.063    4.311    \<0.001
   Age (years)                                             0.501    26.449   \<0.001   0.358    21.824   \<0.001
   Females/males                                           −0.098   −5.900   \<0.001   0.054    3.729    \<0.001
   pPP (mmHg)                                              0.196    11.262   \<0.001   0.466    30.843   \<0.001
   FBG (mmol/L)                                            0.053    3.314    0.001     −0.015   −1.076   0.282
   HDL-C (mmol/L)                                          −0.060   −3.489   \<0.001   −0.001   −0.082   0.935
   LDL-C (mmol/L)                                          −0.021   −1.206   0.228     0.013    0.895    0.371
  **WC (cm)**                                                                                            
  First model[a](#tfn5-cia-8-1579){ref-type="table-fn"}                                                  
   WC (cm)                                                 0.075    4.256    \<0.001   0.077    4.428    \<0.001
   Age (years)                                             0.563    31.865   \<0.001   0.551    31.511   \<0.001
   Females/males                                           −0.101   −5.823   \<0.001   0.048    2.798    0.005
  Second model[b](#tfn6-cia-8-1579){ref-type="table-fn"}                                                 
   WC (cm)                                                 0.036    1.897    0.048     0.021    1.257    0.209
   Age (years)                                             0.492    25.212   \<0.001   0.354    20.893   \<0.001
   Females/males                                           −0.090   −5.245   \<0.001   0.060    3.981    \<0.001
   pPP (mmHg)                                              0.191    10.960   \<0.001   0.470    31.038   \<0.001
   FBG (mmol/L)                                            0.050    3.148    0.002     −0.014   −1.006   0.315
   HDL-c (mmol/L)                                          −0.041   −2.335   0.020     −0.016   −1.078   0.281
   LDL-c (mmol/L)                                          −0.027   −1.591   0.112     0.018    1.208    0.227

**Notes:**

First model: adjusted by age and sex

second model: adjusted by age, sex, pPP, FBG, HDL-C, and LDL-C.

**Abbreviations:** cfPWV, carotid-femoral pulse wave velocity; cPP, central pulse pressure; BMI, body mass index; WC, waist circumference; pPP, peripheral pulse pressure; FBG, fasting blood glucose; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.
